Kyash images

We are confident that our focus on developing proprietary payment technology and strategic merchant network partnerships continues to bring value to users and addresses the need for remote financial transactions in a digital economy

TOKYO (PRWEB)
March 31, 2020

Kyash has raised $45 million in a Series C Funding round co-led by Greenspring Associates and Goodwater Capital, a global consumer technology investor along with several venture capital firms from around the world to accelerate its full-stack mobile banking business in Japan. Total funds raised as of today are $73 million.

Investors in the round include Goodwater Capital, which initially invested in Kyash’s Series B Round, Greenspring Associates, a global venture capital investment platform with over $10 billion in assets under management, Greyhound Capital, a UK growth equity investment firm, US venture capital firm Altos Ventures, global investment firm Partech Partners, US FinTech venture capital fund Broadhaven Ventures, US venture capital firm Tekton Ventures, and Mr. Rahul Mehta, Managing Partner of DST Global. This is the first time Greenspring Associates, Partech, and Broadhaven Ventures have invested in a Japanese startup. Previous investor JAFCO also participated and remains committed to supporting Kyash’s vision.

The funding will be used to further Kyash’s overall growth strategy and business domain expansion, particularly into the banking space. ​

Since October 2019, Japan has undergone a nationwide cashless transformation driven by the government’s subsidization of a portion of cashless payments. This transformation has become even more pressing with the onset of the coronavirus pandemic. With social distancing protocols being enforced worldwide, cashless payments are quickly becoming the norm, reducing physical contact and making people’s lives easier, safer, and less stressful during this difficult time.

“I am delighted to announce Kyash’s partnerships with these global investors as a result of the company’s progress in product development and significant user traction in Japan amid the uncertain market conditions resulting from the widespread effects of the pandemic,” said Shinichi Takatori, Founder & CEO of Kyash. “We are confident that our focus on developing proprietary payment technology and strategic merchant network partnerships continues to bring value to users and addresses the need for remote financial transactions in a digital economy.”

About Kyash

Kyash is a Tokyo-based fast growing mobile financial startup that offers a mobile banking experience to consumers. Founded in 2015, the company’s mission is to create a new financial infrastructure to transform the Japanese banking landscape. Kyash’s proprietary payment processing technology facilitates better unit economics and more flexibility around product development. Investors in the company include all three major Japanese mega bank groups, as well as global venture capital firms. Kyash has also made its APIs available to other business partners for their payment services by issuing Visa cards.

Share article on social media or email:

“The COVID-19 Alerts and Reporting Solution make sense of the confusing collection of data to prevent the transmission of COVID-19,” said Gregg Church, president of 4medica.

MARINA DEL REY, Calif. and LINCOLN, Neb. (PRWEB)
March 31, 2020

4medica® and KPI Ninja announced today teaming up to launch a comprehensive lab analytics solution to support rapid treatment, prevention and spread of the COVID-19 (coronavirus) pandemic. The COVID-19 Alerts and Reporting Solution™ helps healthcare organizations and medical professionals identify and prioritize patients at higher risk of contracting severe forms of the respiratory disease. The solution also finds and tracks healthcare facility and ICU bed utilization across the U.S.

The Centers for Disease Control and Prevention (CDC) reports, “In the event of a discrepancy between CDC cases and cases reported by state and local public health officials, data reported by states should be considered the most up to date.” This statement points to a national need for precise data to identify and track suspected or confirmed patient cases concurrently with the availability of bed capacity. First responders, hospitals, health systems, medical practices, ACOs, HIEs and public health agencies need the data insights to make informed decisions mobilizing people and facilities to care for the growing number of cases in various regions across the U.S.

The COVID-19 Alerts and Reporting Solution integrates the 4medica Lab Hub™ and KPI’s Ninja Universe analytics platform to provide real-time lab pandemic analytics and ADT notifications. Commercial laboratories such as Quest Diagnostics, LabCorp, BioReference Laboratories and public health laboratories send results to 4medica to normalize and match to the right patient identity. The validated data is then submitted to the Ninja Universe platform to analyze and share with the appropriate front-line providers, public health agencies and patients.

Nebraska Health Information Initiative (NEHII) is the first health information exchange using the solution to analyze the risk, prevalence and characteristics of COVID-19 cases and perform risk stratification analysis of other social resources and factors impacted by the virus across the state of Nebraska.

“The COVID-19 Lab Alerts and Reporting Solution augments our HIE to report accurate, knowledge-based data that informs life-saving decisions and community emergency prevention efforts at a time of unprecedented need,” said Jaime Bland, NEHII CEO.

“The COVID-19 Alerts and Reporting Solution make sense of the confusing collection of data to prevent the transmission of COVID-19,” said Gregg Church, president of 4medica. “While interoperability is a persistent challenge in the U.S. healthcare system, we’ve proactively built a solution that interprets the data into clear, succinct and actionable knowledge to help healthcare organizations address critical COVID-19 pandemic issues quickly and efficiently.”

“The solution immediately equips frontline healthcare workers with the right, accurate data they need to perform their jobs at the highest level,” said Vineeth Yeddula, CEO of KPI Ninja. “Whether this is a first responder’s having real-time data to locate the best hospital to transfer a patient or a state authority needing a density map to pinpoint case surges regionally, the solution’s detailed output supports decision-makers strategizing and allocating appropriate emergency response and resources for people requiring the greatest amount of aid.”

Journalists: Click here to download a screenshot of COVID-19 Alerts and Reporting Solution.

About 4medica

Guaranteeing an unprecedented 1% patient record duplication rate, 4medica® solves data integrity and financial challenges to minimize patient safety and other clinical risks and achieve true clinical interoperability and transparency for patients. Our Big Data Management and Clinical Data Exchange cloud solutions help healthcare organizations facilitate patient identity management and data exchange to ensure the right data is captured at the right time, the first time. 4medica’s Perfect Order for Perfect Payment™ ensures labs and imaging centers get paid by integrating high-volume revenue cycle management services throughout the entire order management process. 4medica has processed up to 6 billion clinical results representing more than 70 million patient identities. The company connects 40,000-plus physicians to hundreds of ACOs, HIEs, HINs, hospitals, health systems, laboratories, radiology imaging centers and payers nationwide. Learn more at http://www.4medica.com.

About KPI Ninja

KPI Ninja is a healthcare analytics company that supports healthcare organizations to meet their population health and value-based initiatives. Using our signature mix of innovative technology solutions and services, we work shoulder-to-shoulder with clients to accelerate goal achievement. In harmony with our data-centered ethos, we truly believe that our success is strongly correlated with yours. We are differentiated by our comprehensive capabilities that transcend value-based programs and data sources to support stakeholders’ use of data to improve outcomes. Our platform is aligned to initiatives led by CMS, ONC, NCQA, including holding NCQA’s eCQM Certification, Measure Certification for HEDIS® Health Plan 2020, PCMH and PCSP Prevalidation; demonstrating our commitment to providing you a trusted brand.

Share article on social media or email:

We are concentrating all of our efforts on making our solutions available to health authorities fighting against this pandemic.

ATLANTA (PRWEB)
March 31, 2020

COVID-19 by Hayver announces the launch of a comprehensive, end-to-end solution utilizing smartphone technology, metadata and predictive analytics to stop the spread of COVID-19 and help people to go safely back to work. COVID-19 by Hayver monitors, tracks and holds accountable populations, while respecting privacy, in order to 1) mitigate COVID-19 community spread, 2) protect vulnerable populations, 3) manage quarantines and isolations, 4) monitor viral expansion so resources can be applied in a directed fashion and 5) enable society to go back to normal in a controlled manner, once the viral expansion has been contained.

“We are concentrating all of our efforts on making our solutions available to health authorities fighting against this pandemic,” Hayver CEO Barry Hayut said. “We believe that we have the platform to dramatically load-balance their work, and ensure their efforts are efficient in regards to protecting the population and stopping the spread of COVID-19.”

Hayver’s solution includes a Daily Diary screening tool that collects HIPAA-compliant data points for COVID-19 tracking and management. Members will check in daily and relay information such as any symptoms of fever, cough or difficulty breathing, along with any possible contact with a COVID-19 infected-person. Users are asked additional questions regarding feelings of confusion, difficulty waking up, or any new or developing aches and pains, and more.

As well, the platform’s GPS tracking ability allows for contact tracing, which permits healthcare professionals to more easily track the spread of the infection and understand who has recovered, who is infectious and who is trending towards becoming infected.

Hayver has also embedded into the COVID-19 by Hayver system its Circle of Support program to allow participants to include family members or individuals living in the same household, and contacts, who can be notified about any changes concerning their health status. This Early Warning System helps the user and their family to identify possible cross-infection situations and then be able to notify the proper health authorities to receive prioritized care.

Hayut has gone on to say, “This COVID-19 system by Hayver provides information to the patient about their best ‘next steps’, based on their exposure and symptomatology; additionally, by aggregating the information from many individuals in a geographic area, healthcare organizations and governments can predict resource requirements and load balance the requirements with the available supplies and personnel. By providing real-time phone-location data, and geo-fencing, to track the movements of virus carriers and the people they come in contact with, containment and flattening of the curve is potentially within our grasp.”

Whether it’s going in to obtain urgent care, being in quarantine, isolating from others, wearing a face mask, or social distancing, the science drives the recommendation and the individual can be optimally informed so they can take the appropriate precautions. With the ability to provide testing advice and alter these parameters as we learn more, COVID-19 by Hayver informs the individual when and where to be tested, and ensures that the right people are able to obtain access to limited resources.

Through anonymized data, Health Authorities can also better understand where infections are growing or peaking, how they are spreading (travel vs. community), if travelers are abiding by self-isolation protocols, and when wholesale policies such as mass quarantines need to be implemented to forestall the spread of COVID-19.

Contact tracing is a critical component of dampening the viral spread; and the average person cannot possibly know or remember everywhere they have traveled in the last two weeks. Identification and notification can be done anonymously, to ensure privacy and still support public health goals.

The platform also enables healthcare professionals to communicate with the user in one-on-one or one-on-many telecommunication sessions to provide treatment information, as well as educational and instructional information — or area-wide alerts or warnings. Additional informational content, such as videos and documents, can be distributed through the platform to help facilitate the flow of information to the user. The platform allows professionals to distribute information easily, saving them time and easing the workload on healthcare workers.

Since 2017, Hayver has operated a HIPAA-compliant, smart phone-based population monitoring and accountability app, with a complete analytical, predictive platform to monitor and change health-related behaviors. The company has developed and successfully tested in “real life” the monitoring system for one of the least compliant populations: alcohol and drug addicts.

For more information, contact:

Barry Hayut, Co-Founder, CEO

BHayut@Hayver.com

Phone number: 678-701-9122

Share article on social media or email:

“Dr. Philip Brodak has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

PLEASANTON, Calif. (PRWEB)
March 31, 2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Philip Brodak, M.D., Tri Valley Urology in Murrieta, CA, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Brodak has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Philip Brodak has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Willful Launches Free Wills for Healthcare Workers

We’ve seen an increasing number of Canadians discussing end-of-life planning with loved ones and turning to tools like Willful to complete their estate plan while social distancing, and we hope this makes it easier for healthcare workers to get these documents finalized.

TORONTO (PRWEB)
March 31, 2020

Today Toronto-based estate planning platform Willful announced it has partnered with U.S.-based Trust & Will to offer thousands of free wills and Power of Attorney documents to frontline healthcare workers in the U.S. and Canada who are working in hospitals and urgent care centres treating COVID-19. Healthcare administrators in both countries have called for doctors, nurses, and other frontline healthcare professionals to get these documents in order since their jobs result in higher exposure to the virus. Online platforms like Willful and Trust & Will make it easy for anyone to create a legally-binding will and Power of Attorney documents online in less than 20 minutes, giving healthcare workers an easy way to complete these documents without having to visit a lawyer. An AngusReid survey conducted by Willful showed that 57% of Canadian adults don’t have a will, of those who do, 10% are out-of-date.

“We’re incredibly grateful to the healthcare workers who are risking their lives to keep us safe, and as a Canadian small business, we wanted to do whatever we could to help our local frontline workers who are treating COVID-19 patients,” said Erin Bury, co-founder & CEO, Willful. “We’ve seen an increasing number of Canadians discussing end-of-life planning with loved ones and turning to tools like Willful to complete their estate plan while social distancing, and we hope this makes it easier for healthcare workers to get these documents finalized.”

Willful launched in 2017 and has helped thousands of Canadians create their wills and Power of Attorney documents from home. The platform offers three plans catered to singles and couples ranging from $99-249, and as part of this initiative the company will be giving away 1,000 of its Premium plans, each valued at $149, until April 30. The Premium plan comes with three documents: a will, which allows users to plan for what happens when they pass away, and two Power of Attorney documents, which allow users to appoint someone to make medical and financial decisions in case they become incapacitated. Each plan also comes with free will registry on the CanadaWillRegistry, a $35 value.

Canadian law requires that wills are printed, signed, and witnessed correctly in order to be legally-valid, which presents challenges for anyone social distancing, self-isolating, or quarantining. Since many Canadians have lost access to a printer, Willful is offering free printing and shipping of documents for a limited time. The company also created a guide outlining how to get a will signed and witnessed during COVID-19. Recognizing the limitations in current laws, Willful partner NoticeConnect, the owner of the CanadaWillRegistry, launched a petition to amend the law to recognize virtual witnesses to address this issue.

Willful is available in seven Canadian provinces, and the company has partnered with San Diego-based Trust & Will to refer customers to each other’s services. Trust & Will’s modern estate planning platform is available nationwide, and executed the first digital Will (eWill) in 2019 in Nevada. Several U.S. states now allow for the digital signing of Wills. Trust & Will is offering free Wills, Power of Attorney, and Healthcare Directive documents to frontline healthcare workers in the U.S., where COVID-19 cases are now the highest globally.

“As a husband to a spouse who works in a hospital, and whose colleagues are like family to us, it hit close to home seeing the risk that healthcare professionals are putting themselves in every day right now. The last thing that should be weighing down on any healthcare professional, especially if they are a parent, is not having an estate plan in place,” said Cody Barbo, CEO, Trust & Will. “We are grateful to be working with our friends to the North at Willful, to help spread the word about their offer to help Canadian healthcare professionals. We are all in this together!”

To learn more about Willful’s initiative for healthcare workers, visit willful.co/support-healthcare

To learn more about Trust & Will’s initiative for healthcare workers, visit trustandwill.com/frontline-heroes

About Willful

Willful’s mission is to change the way Canadians prepare for and deal with death. Their first product is an online platform that makes it affordable, convenient, and easy for Canadians to create a legal will online. The platform provides simplified estate planning services (creation of a Legal Will and Power of Attorney documents), enabling consumers to create a will and/or power of attorney by following a clear step-by-step process. Willful’s platform was developed in collaboration with leading estate lawyers, with pricing plans starting at $99. Willful is based in Toronto, and it is currently available to residents of Ontario, British Columbia, Saskatchewan, Manitoba, Alberta New Brunswick, and Nova Scotia.

Share article on social media or email: